Hafez Selim
A drug-drug interaction warning tells you that two medicines can interact. It does not tell you whether they did, whether it mattered for this patient, or what a safety organization should do about it. This book closes that gap.Written by a physician-scientist with more than 20 years in drug safety and pharmacovigilance, Drug-Drug Interactions in Drug Safety and Pharmacovigilance gives drug safety physicians, pharmacists, PV scientists, medical monitors, and newcomers to the field a practical method for taking an interaction warning to a defensible safety conclusion. One principle runs through every chapter: coadministration creates the opportunity for an interaction; it does not prove the interaction caused the event.Across six parts and 26 chapters you will learn to:Judge clinical relevance for a specific patient and compare the evidence behind a warningApply absorption, metabolic, transporter, pharmacodynamic and timing mechanisms, including biologics and complex regimensReconstruct real medication exposure in incomplete case reports, weigh competing explanations, and write defensible narratives and reporting decisionsBuild case series, run quantitative interaction screening, and validate and prioritize signalsTurn assessment into action in clinical trials, aggregate reports, benefit-risk evaluation, labeling and risk minimizationEvery chapter ends with a finished work product - a screening checklist, follow-up request, medical assessment, line listing, signal report or monitoring plan - with annotated worked answers. A companion workbook and free online toolkit of calculators, worksheets and teaching datasets support hands-on practice, and two integrated workshops bring the whole method together.This is not an interaction encyclopedia. It is a method for making your reasoning visible to colleagues, auditors and regulators.